Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A new framework for novel analogues of pazopanib as potent and selective human carbonic anhydrase inhibitors: Design, repurposing rational, synthesis, crystallographic, in vivo and in vitro biological assessments
Salma M. Hefny, Tarek F. El‐Moselhy, Nabaweya Sharaf El-Din, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116527-116527
Closed Access | Times Cited: 16

Showing 16 citing articles:

Design, synthesis, and molecular dynamics-driven evaluation of quinoline-sulfonamide derivatives as potent and selective EGFR inhibitors with promising anti-cancer efficacy and safety profiles
Mahmoud S. Elkotamy, Mohamed K. Elgohary, Islam A. Elkelesh, et al.
Bioorganic Chemistry (2025), pp. 108247-108247
Closed Access | Times Cited: 2
Unveiling the potential of isatin-grafted phenyl-1,2,3-triazole derivatives as dual VEGFR-2/STAT-3 inhibitors: Design, synthesis and biological assessments
Heba A. Elsebaie, Maha-Hamadien Abdulla, Zainab M. Elsayed, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107626-107626
Closed Access | Times Cited: 10
Modulation of AMPK by esomeprazole and canagliflozin mitigates methotrexate-induced hepatotoxicity: involvement of MAPK/JNK/ERK, JAK1/STAT3, and PI3K/Akt signaling pathways
Ahmed M. El‐Dessouki, Mohamed E. Kaml, Mohammed F. EL-Yamany
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access | Times Cited: 1
Shooting an Arrow against Convulsion: Novel Triazole-Grafted Benzenesulfonamide Derivatives as Carbonic Anhydrase II and VII Inhibitors
Mohamed A. Zeidan, Mahmoud Abdelrahman Alkabbani, Simone Giovannuzzi, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
Identification of indole-grafted pyrazolopyrimidine and pyrazolopyridine derivatives as new anti-cancer agents: Synthesis, biological assessments, and molecular modeling insights
Wagdy M. Eldehna, Haytham O. Tawfik, Maha-Hamadien Abdulla, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107804-107804
Closed Access | Times Cited: 6
Design, Synthesis, Anticancer Screening, and Mechanistic Study of Spiro-N-(4-sulfamoyl-phenyl)-1,3,4-thiadiazole-2-carboxamide Derivatives
Ahmed M. M. El‐Saghier, Hamada H. H. Mohammed, Sherif A. Maher, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 863-863
Open Access
Development of novel amino-benzenesulfonamide derivatives and their analogues as carbonic anhydrase inhibitors: Design, synthesis, anticancer activity assessment, and pharmacokinetic studies using UPLC-MS/MS
Khaled Elsayad, Ghada F. Elmasry, Sally Tarek Mahmoud, et al.
Bioorganic Chemistry (2025) Vol. 159, pp. 108335-108335
Closed Access
Design and synthesis of novel substituted s‐triazines tethered benzenesulfonamides as potential antimicrobial candidates: Antibiofilm and bacterial protein permeability assessments
Ahmed A. Al‐Karmalawy, Haytham O. Tawfik, Gharieb S. El‐Sayyad, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 3
Closed Access
Melatonin augments anti-tumor activity and alleviates nephrotoxicity of gemcitabine in a pancreatic cancer xenograft model targeting P62/Keap1 pathway
Samar Ibrahim, Eman H. Yousef, Ahmed M. El‐Dessouki, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
Targeting DNA repair mechanisms: Spirobenzoxazinone and salicylamide derivatives as novel candidates for PARP-1 inhibition in cancer therapy
Abdelrazak M. Kadry, Mai Adel, Samar A. Abubshait, et al.
Bioorganic & Medicinal Chemistry (2025), pp. 118173-118173
Closed Access
Comprehensive Insights into Carbonic Anhydrase Inhibition: A Triad of In vitro, In silico, and In vivo Perspectives
Ahmed A. Allam, Hassan A. Rudayni, Noha Ahmed, et al.
Enzyme and Microbial Technology (2025) Vol. 189, pp. 110657-110657
Closed Access
Novel benzofuran-conjugated indolin-2-ones as anticancer agents; design, synthesis, biological assessments, and molecular modeling insights
Wagdy M. Eldehna, Haytham O. Tawfik, Mohamed S. Nafie, et al.
Bioorganic Chemistry (2025), pp. 108494-108494
Closed Access
Development of isatin-functionalized benzenesulfonamides as novel Carbonic Anhydrase II and VII Inhibitors with Antiepileptic Potential
Wagdy M. Eldehna, Anwar A. El-Hamaky, Simone Giovannuzzi, et al.
European Journal of Medicinal Chemistry (2025) Vol. 292, pp. 117706-117706
Closed Access
Fragment-based design and synthesis of coumarin-based thiazoles as dual c-MET/STAT-3 inhibitors for potential antitumor agents
Bassem H. Naguib, Heba A. Elsebaie, Mohamed S. Nafie, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107682-107682
Closed Access | Times Cited: 2
Carbonic anhydrases: Moiety appended derivatives, medicinal and pharmacological implications
Aashish Jaitak, K Sunanda Kumari, Sanjay Kounder, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 114, pp. 117933-117933
Closed Access | Times Cited: 2
Green One-Pot Synthesis of Thiazole Scaffolds Catalyzed by Reusable NiFe2O4 Nanoparticles: In Silico Binding Affinity and In Vitro Anticancer Activity Studies
Satish Gudala, Archi Sharma, Aruna Lankada, et al.
ACS Omega (2024) Vol. 9, Iss. 36, pp. 38262-38271
Open Access
Page 1

Scroll to top